FLURF FluroTech Ltd.

FluroTech Ltd. engages in the commercialization of new technologies in the cannabis and hemp industries. The firm's proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples derived from cannabis plants. Its products include a two-part solution comprising an instrument called the CompleTest and consumable testing kits. The company was founded by Danny Dalla-Longa and Elmar J. Prenner on May 24, 2018 and is headquartered in Calgary, Canada.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.07    OTCQB
As of 01/24/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  Medical Devices
Index country:  Canada
Country of incorporation:  
IPO date:  01/14/2019
Outstanding shares:  120,685,541
Average volume:  9,698
Market cap:   $8,930,730
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   -11.02
PB ratio:   1.10
PS ratio:   -52.79
Return on equity:   -50.51%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy